eFFECTOR Therapeutics, Inc. (EFTR) Social Stream



eFFECTOR Therapeutics, Inc. (EFTR): $1.84

0.05 (+2.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EFTR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 433

in industry

eFFECTOR Therapeutics Inc (EFTR) Price Targets From Analysts

Use the tables below to see what analysts covering eFFECTOR Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $50 $20 $30.75 $3.82 704.97%
2022-01-25 4 $50 $6.2 $27.3 $3.82 614.66%
2022-03-17 4 $50 $4 $26.75 $3.82 600.26%

EFTR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EFTR as an investment opportunity.

  • In terms of how eFFECTOR Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 292.32% of that group.
  • EFTR has a lower variance in analysts' estimates than -188.8% of all US stocks.
  • In terms of how eFFECTOR Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 68.94% of that group.
  • In terms of how eFFECTOR Therapeutics Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 193.78% of that group.

Stocks similar to eFFECTOR Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DYN, DSGN, and DRRX.

Is EFTR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4905 seconds.